Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Bipolar Disorder: HELP
Elisa Brietzke
Based on 51 articles published since 2007
||||
Expertise Level
The expertise of Elisa Brietzke ranks in the
  • Top 0.16%
  • ... of 33,806 published authors worldwide on Bipolar Disorder
  • ... from 2007 through 2018
  • ... based on contributions to 51 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Brietzke, E   ·   Brietzke, Elisa
Work Locations
Details
Most likely:    University Health Network of Toronto      
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
2012
  • University of Toronto, Canada University Health Network, Canada. · Pubmed 22849038
Probable:    Universidade Federal de Sao Paulo      
2017
  • Centro Interdisciplinar de Neuromodulação Clínica, Faculdade de Ciências Médicas, Santa Casa de São Paulo, São Paulo, SP, Brazil. · University of California (UCLA), San Diego, USA. · Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Pubmed 28403323
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Laboratório Interdisciplinar de Neurociências Clínicas (LINC), UNIFESP, São Paulo, SP, Brazil. · Programa de Intervenção em Estados Mentais de Risco (PRISMA), Departamento de Psiquiatria, UNIFESP, São Paulo, SP, Brazil. · Laboratório de Psiquiatria Molecular, Instituto Nacional de Ciência e Tecnologia - Medicina Translacional (INCT-TM), Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. · Programa de Pós-Graduação em Medicina, Departamento de Psiquiatria, UFRGS, Porto Alegre, RS, Brazil. · Departamento de Farmacologia, UFRGS, Porto Alegre, RS, Brazil. · Academic Psychiatry, Institute of Neuroscience, Newcastle University, UK. · Centre for Affective Disorders, Institute of Psychiatry, King's College London, London, UK. · Pubmed 27533022
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil. · Genetics Division, Department of Morphology and Genetics, UNIFESP, São Paulo, Brazil. · LiNC-Interdisciplinary Laboratory of Clinical Neurosciences, UNIFESP, São Paulo, Brazil. · Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, São Paulo, Brazil. · Department of Pharmacology, UNIFESP, São Paulo, Brazil. · Research Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, UNIFESP, São Paulo, Brazil. · Pubmed 27701407
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
  • Laboratório de Psiquiatria Molecular, Instituto Nacional de Ciência e Tecnologia - Medicina Translacional (INCT-MT), Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. · Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Pubmed 27111704
2015
  • Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. · Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Pubmed 25806550
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, SP, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, UNIFESP, São Paulo, SP, Brazil. · Developmental Cognitive Neuroscience Research Group (GNCD), Centre of Studies and Research in Traumatic Stress (NEPTE), Biomedical Research Institute, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. · The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, New York, NY, USA. · Pubmed 26692432
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Universidade Federal de São Paulo, São Paulo, Brazil; Sleep Institute, Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil. · Sleep Institute, Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Universidade Federal de São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Universidade Federal de São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 26391284
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Program of Mood and Anxiety Disorders (CETHA), Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil. · Department of Clinical Medicine, Health Sciences Center, Universidade Estadual de Londrina (UEL), Londrina, PR, Brazil. · First Psychotic Episode Program, Department of Psychiatry, UNIFESP, São Paulo, SP, Brazil. · Ambulatório Médico de Especialidades (AME) Dra. Jandira Masur, São Paulo, SP, Brazil. · Developmental Cognitive Neuroscience Research Group (GNCD), Center of Studies and Research in Trauma and Stress (NEPTE), Biomedical Research Institute (IPB), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil. · The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, NY, USA. · Pubmed 26692427
  • Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. Electronic address: · Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of São Paulo, São Paulo, Brazil. · Laboratory of Molecular Psychiatry, INCT for Translational Medicine, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. · Department of Mental Health, Federal University of Minas Gerais, Belo Horizonte, Brazil. · Pubmed 26241664
  • Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. Electronic address: · PRISMA/PROESQ - Departamento de Psiquiatria, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Instituto Federal Sudeste de Minas Gerais, Campus Barbacena, Barbacena, Brazil. · Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil; Departamento de Neurologia e Neurocirurgia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Pubmed 26220853
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. Electronic address: · INCT-CNPq and Federal University of Rio Grande do Sul, Brazil. · Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. · INCT-CNPq and University of São Paulo, Brazil. · King's College London, UK. · National Institute of Mental Health (NIMH), USA. · Pubmed 24839881
2013
  • Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23484676
2012
  • Program for Recognition and Intervention in Individuals in at Risk Mental State, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22613185
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22406334
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22365650
2013
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23898851
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Pubmed 23489403
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23266709
  • Psychiatric Unit, Hospital São Paulo, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 23764349
Probable:    University of Sao Paulo      
2017
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. Electronic address: · Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of São Paulo, São Paulo, Brazil. · Laboratory of Molecular Psychiatry, INCT for Translational Medicine, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. · Department of Mental Health, Federal University of Minas Gerais, Belo Horizonte, Brazil. · Pubmed 26241664
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. Electronic address: · INCT-CNPq and Federal University of Rio Grande do Sul, Brazil. · Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. · INCT-CNPq and University of São Paulo, Brazil. · King's College London, UK. · National Institute of Mental Health (NIMH), USA. · Pubmed 24839881
2012
  • Bipolar Disorder Program, Institute of Psychiatry, Universidade de São Paulo, São Paulo, Brazil. · Pubmed 22104557
2011
  • Bipolar Disorder Program, Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Pubmed 21721918
  • Department and Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Pubmed 21071093
  • Bipolar Disorder Program, Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Pubmed 20832177
2013
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Pubmed 23489403
  • Psychiatric Unit, Hospital São Paulo, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 23764349
2011
  • Bipolar Disorder Research Program, Department of Psychiatry, Medical School, University of São Paulo, São Paulo, Brazil. · Pubmed 20828594
  • Bipolar Disorders Research Program, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil. · Pubmed 21372622
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 51 total) written by Elisa Brietzke about Bipolar Disorder:

  • Microbiota abnormalities and the therapeutic potential of probiotics in the treatment of mood disorders. 2017
  • A critical review of trials of transcranial direct current stimulation and trigeminal nerve stimulation for depression: the issue of treatment-emergent mania. 2017
  • Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems. 2017
  • BDNF and BMI effects on brain structures of bipolar offspring: results from the global mood and brain science initiative. 2017
  • A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. 2017
  • Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study. 2017
  • Challenges and developments in research of the early stages of bipolar disorder. 2016
  • Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. 2016
  • Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis. 2016
  • Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder. 2016
Show List of Full Article Records
Google Searches

Learn more about Elisa Brietzke using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University Health Network of Toronto
Universidade Federal de Sao Paulo
University of Sao Paulo
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University Health Network of Toronto
2017
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
2014
  • Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Pubmed 24330342
2012
  • University of Toronto, Canada University Health Network, Canada. · Pubmed 22849038
Universidade Federal de Sao Paulo
2017
  • Centro Interdisciplinar de Neuromodulação Clínica, Faculdade de Ciências Médicas, Santa Casa de São Paulo, São Paulo, SP, Brazil. · University of California (UCLA), San Diego, USA. · Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Pubmed 28403323
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Department of Affective Disorders, the Affiliated Hospital of Guangzhou Medical University, (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA. · Laboratory of Emotion and Cognition, the Affiliated Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou Medical University, Guangzhou, China. · Laboratory of Neuropsychology, University of Hong Kong, Hong Kong, Hong Kong. · Pubmed 29023633
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Electronic address: · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Research Division, Institute of Mental Health, Singapore. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Department of Psychiatry, Stanford University, Palo Alto, CA, United States. · Department of Psychiatry, Dalhousie University, Halifax, Canada. · Pubmed 27721184
2016
  • Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Laboratório Interdisciplinar de Neurociências Clínicas (LINC), UNIFESP, São Paulo, SP, Brazil. · Programa de Intervenção em Estados Mentais de Risco (PRISMA), Departamento de Psiquiatria, UNIFESP, São Paulo, SP, Brazil. · Laboratório de Psiquiatria Molecular, Instituto Nacional de Ciência e Tecnologia - Medicina Translacional (INCT-TM), Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. · Programa de Pós-Graduação em Medicina, Departamento de Psiquiatria, UFRGS, Porto Alegre, RS, Brazil. · Departamento de Farmacologia, UFRGS, Porto Alegre, RS, Brazil. · Academic Psychiatry, Institute of Neuroscience, Newcastle University, UK. · Centre for Affective Disorders, Institute of Psychiatry, King's College London, London, UK. · Pubmed 27533022
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil. · Genetics Division, Department of Morphology and Genetics, UNIFESP, São Paulo, Brazil. · LiNC-Interdisciplinary Laboratory of Clinical Neurosciences, UNIFESP, São Paulo, Brazil. · Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, São Paulo, Brazil. · Department of Pharmacology, UNIFESP, São Paulo, Brazil. · Research Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, UNIFESP, São Paulo, Brazil. · Pubmed 27701407
  • Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Pubmed 27488494
  • Department of Psychiatry, Research Group in Behavioral Neuroscience of Bipolar Disorder (GP-TB), Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, Brazil. · Psychiatric Center Copenhagen, University of Copenhagen, Copenhagen, Denmark. · Bipolar Disorder Program and Laboratory of Molecular Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. · Pubmed 27324989
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Medical University of Graz, Department of Psychiatry, Graz, Austria. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 27281261
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26866976
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
  • Laboratório de Psiquiatria Molecular, Instituto Nacional de Ciência e Tecnologia - Medicina Translacional (INCT-MT), Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. · Laboratório Interdisciplinar de Neurociências Clínicas (LiNC), Departamento de Psiquiatria, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Pubmed 27111704
2015
  • Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. · Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Pubmed 25806550
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, SP, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, UNIFESP, São Paulo, SP, Brazil. · Developmental Cognitive Neuroscience Research Group (GNCD), Centre of Studies and Research in Traumatic Stress (NEPTE), Biomedical Research Institute, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brazil. · The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, New York, NY, USA. · Pubmed 26692432
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Universidade Federal de São Paulo, São Paulo, Brazil; Sleep Institute, Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil. · Sleep Institute, Department of Psychobiology, Universidade Federal de São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Universidade Federal de São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Universidade Federal de São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 26391284
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Program of Mood and Anxiety Disorders (CETHA), Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil. · Department of Clinical Medicine, Health Sciences Center, Universidade Estadual de Londrina (UEL), Londrina, PR, Brazil. · First Psychotic Episode Program, Department of Psychiatry, UNIFESP, São Paulo, SP, Brazil. · Ambulatório Médico de Especialidades (AME) Dra. Jandira Masur, São Paulo, SP, Brazil. · Developmental Cognitive Neuroscience Research Group (GNCD), Center of Studies and Research in Trauma and Stress (NEPTE), Biomedical Research Institute (IPB), Pontificia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil. · The Zucker Hillside Hospital, Psychiatry Research, North Shore - Long Island Jewish Health System, Glen Oaks, NY, USA. · Pubmed 26692427
  • Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. Electronic address: · Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of São Paulo, São Paulo, Brazil. · Laboratory of Molecular Psychiatry, INCT for Translational Medicine, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. · Department of Mental Health, Federal University of Minas Gerais, Belo Horizonte, Brazil. · Pubmed 26241664
  • Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. Electronic address: · PRISMA/PROESQ - Departamento de Psiquiatria, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Instituto Federal Sudeste de Minas Gerais, Campus Barbacena, Barbacena, Brazil. · Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil; Departamento de Neurologia e Neurocirurgia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Departamento de Psicobiologia, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Pubmed 26220853
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. Electronic address: · INCT-CNPq and Federal University of Rio Grande do Sul, Brazil. · Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. · INCT-CNPq and University of São Paulo, Brazil. · King's College London, UK. · National Institute of Mental Health (NIMH), USA. · Pubmed 24839881
2013
  • Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23484676
2012
  • Program for Recognition and Intervention in Individuals in at Risk Mental State, Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22613185
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22406334
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 22365650
2013
  • Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23898851
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Pubmed 23489403
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Pubmed 23266709
  • Psychiatric Unit, Hospital São Paulo, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 23764349
University of Sao Paulo
2017
  • University of São Paulo (USP), São Paulo, Brazil; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Federal University of São Paulo (Unifesp), São Paulo, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network (UHN), University of Toronto, Toronto, Canada. Electronic address: · Pubmed 28107669
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, Kuwait University, Kuwait City, Kuwait. · Psychosocial Oncology Clinic, University Health Network, Toronto, ON, Canada. · Department of Psychology, University of Toronto, Toronto, ON, Canada. · Neuropsychology Clinic, University Health Network, Toronto, ON, Canada. · Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Department of Psychiatry, Women's College Hospital, Toronto, ON, Canada. · Department of Toxicology and Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 28599348
2016
  • Mood Disorders Psychopharmacology Unit, University Health Network, Department of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Psychiatry, Western University, London and Windsor, ON, Canada. · IMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, Vic., Australia. · Department of Psychiatry, The Florey Institute of Neuroscience and Mental Health, and Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, University of Melbourne, Parkville, Vic., Australia. · Psychiatric Center Copenhagen, Faculty of Health and Medical Sciences and Department O, University of Copenhagen, Copenhagen, Denmark. · Discipline of Psychiatry, University of Adelaide, Adelaide, SA, Australia. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, São Paulo, Brazil. · Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Departments of Psychiatry, Pharmacology, and Psychological Clinical Science, Centre for Youth Bipolar Disorder, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada. · Pubmed 26990051
  • Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. Electronic address: · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Department of Psychiatry, Clinic for Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; Vila Maria Outpatient Clinic in São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, Canada. · Pubmed 26748249
2015
  • Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Paulo, Sao Paulo, Brazil; Program of Recognition and Intervention in Individuals in AT-Risk Mental States (PRISMA), Department of Psychiatry, Universidade FeInterdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of Sao Pauloderal de São Paulo, São Paulo, Brazil. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26363613
  • Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. Electronic address: · Program of Mood and Anxiety Disorders (CETHA), University Hospital, Federal University of Bahia, Salvador, Brazil; Postgraduate Program in Medicine and Health, Federal University of Bahia, Salvador, Brazil. · Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Federal University of São Paulo, São Paulo, Brazil. · Laboratory of Molecular Psychiatry, INCT for Translational Medicine, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil. · Department of Mental Health, Federal University of Minas Gerais, Belo Horizonte, Brazil. · Pubmed 26241664
2014
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil. · Institute of Biomedical Research and Faculty of Biosciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada. · Program for Recognition and Intervention in Individuals in At-Risk Mental States (PRISMA), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil; Interdisciplinary Laboratory of Clinical Neuroscience (LINC), Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 24548785
  • Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. Electronic address: · INCT-CNPq and Federal University of Rio Grande do Sul, Brazil. · Federal University of São Paulo and the National Institute of Developmental Psychiatry for Children and Adolescents (INCT-CNPq), Brazil. · INCT-CNPq and University of São Paulo, Brazil. · King's College London, UK. · National Institute of Mental Health (NIMH), USA. · Pubmed 24839881
2012
  • Bipolar Disorder Program, Institute of Psychiatry, Universidade de São Paulo, São Paulo, Brazil. · Pubmed 22104557
2011
  • Bipolar Disorder Program, Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Pubmed 21721918
  • Department and Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Pubmed 21071093
  • Bipolar Disorder Program, Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Pubmed 20832177
2013
  • Program for Recognition and Intervention in Individuals in At-Risk Mental States, Department of Psychiatry, Federal University of São Paulo, São Paulo, Brazil. · Pubmed 23489403
  • Psychiatric Unit, Hospital São Paulo, Federal University of São Paulo, São Paulo, Brazil; Program for Recognition and Intervention in Individuals in at Risk Mental States (PRISMA), Federal University of São Paulo, São Paulo, Brazil. Electronic address: · Pubmed 23764349
2011
  • Bipolar Disorder Research Program, Department of Psychiatry, Medical School, University of São Paulo, São Paulo, Brazil. · Pubmed 20828594
  • Bipolar Disorders Research Program, Institute of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil. · Pubmed 21372622
Unspecified
Miscellaneous institutions in Sao Paulo
2016
  • Grupo de Pesquisa em Neurociência Comportamental e Molecular do Transtorno Bipolar, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil. · Laboratório Interdisciplinar de Neurociências Clínicas (LINC), UNIFESP, São Paulo, SP, Brazil. · Programa de Intervenção em Estados Mentais de Risco (PRISMA), Departamento de Psiquiatria, UNIFESP, São Paulo, SP, Brazil. · Laboratório de Psiquiatria Molecular, Instituto Nacional de Ciência e Tecnologia - Medicina Translacional (INCT-TM), Hospital de Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. · Programa de Pós-Graduação em Medicina, Departamento de Psiquiatria, UFRGS, Porto Alegre, RS, Brazil. · Departamento de Farmacologia, UFRGS, Porto Alegre, RS, Brazil. · Academic Psychiatry, Institute of Neuroscience, Newcastle University, UK. · Centre for Affective Disorders, Institute of Psychiatry, King's College London, London, UK. · Pubmed 27533022
  • Department of Psychiatry, Universidade Federal de São Paulo, São Paulo, Brazil. · Department of Psychiatry, Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil. · Genetics Division, Department of Morphology and Genetics, UNIFESP, São Paulo, Brazil. · LiNC-Interdisciplinary Laboratory of Clinical Neurosciences, UNIFESP, São Paulo, Brazil. · Center of Mathematics, Computation and Cognition, Universidade Federal do ABC, São Paulo, Brazil. · Department of Pharmacology, UNIFESP, São Paulo, Brazil. · Research Group in Behavioral and Molecular Neuroscience of Bipolar Disorder, UNIFESP, São Paulo, Brazil. · Pubmed 27701407
Miscellaneous institutions in Porto Alegre
2009
  • Bipolar Disorder Program and Molecular Psychiatry Unit, Hospital de Clínicas de Porto Alegre, UFRGS, Brazil. · Pubmed 19251324
2011
  • Developmental Cognitive Neuroscience Research Group, Postgraduation Program in Psychology - Human Cognition, Pontifical Catholic University, Porto Alegre, Brazil. · Pubmed 21848703
2009
  • Bipolar Disorder Program and Molecular Psychiatry Unit, Hospital de Clínicas, UFRGS, INCT Translational Medicine, Porto Alegre, Brazil. · Pubmed 19666076
Universidade Federal de Rio Grande do Sul
2009
  • Bipolar Disorder Program and Molecular Psychiatry Unit, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil. · Pubmed 19406226
2008
  • Bipolar Disorder Program and Molecular Psychiatry Unit, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul. Porto Alegre, Brazil. · Pubmed 18316149
4 Other Locations Show
Yearly article counts 069737681310
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.